or Try an Advanced Search...

    Cdk Inhibitor Stocks List

    Symbol Grade Name % Change
    CYCCP F Cyclacel Pharmaceuticals, Inc. - 6% Convertible Preferred Stock 0.00
    CYCC F Cyclacel Pharmaceuticals, Inc. -6.46
    View As Page of Charts
    Related Industries: Biotechnology
    Related Stock Lists: Autoimmune And Inflammatory Disease Biology Biopharmaceutical Cancer Cancer Cell Cell Biology Cell Cycle Cell Cycle Checkpoint Cyclacel Cyclin Dependent Kinase Cyclin Dependent Kinase 2 Dna Synthesis Human Cancers Inflammatory Diseases PLK1 Sapacitabine Seliciclib Treatment Of Cancer

    Cdk Inhibitor Stocks Recent News

    Date Stock Title
    Nov 15 CYCC Cyclacel Pharmaceuticals Third Quarter 2024 Earnings: EPS Beats Expectations
    Nov 15 CYCCP Cyclacel Pharmaceuticals Third Quarter 2024 Earnings: EPS Beats Expectations
    Related Industries: Biotechnology
    Related Stock Lists: Autoimmune And Inflammatory Disease Biology Biopharmaceutical Cancer Cancer Cell Cell Biology Cell Cycle Cell Cycle Checkpoint Cyclacel Cyclin Dependent Kinase Cyclin Dependent Kinase 2 Dna Synthesis Human Cancers Inflammatory Diseases PLK1 Sapacitabine Seliciclib Treatment Of Cancer
    Cdk Inhibitor

    CDK inhibitors are drugs that block the activity of cyclin-dependent kinases (CDKs), which are enzymes that play a key role in cell division. CDK inhibitors are used to treat certain types of cancer, as they can stop cancer cells from dividing and growing. They can also be used to treat other conditions, such as autoimmune diseases.

    Browse All Tags